Important Dates

  • Abstract Submission Deadline
    21st October, 2022
  • First Call Registration
    22nd October, 2022
  • Final Call Registration
    10th November, 2022

Hematology Conference 2022

Coalesce Research Group welcomes you to attend and share your research at our upcoming 2nd European Congress on Hematology and Blood Disorders during November 10-11, 2022 at Paris, France with theme To Attain the Innovative Outcomes and Advanced Researches in Hematology. We cordially invite all the speakers, delegates, and students who are interested in sharing their knowledge and research in the area of hematology, blood disorders, and infectious diseases.

Hematology Conference 2022 will support as a stand to bring together scientists, researchers, societies, and all representatives of enterprise regions with different fields such as hematology, blood disorders, and infectious diseases. This conference is an open forum specifically dedicated to young researchers to benefit as well from several specially planned collaborative sessions to spread their research. In specific, the meeting aims to adoptive the spirit of a joint effort among the participants, providing the chance to system worldwide and to launch specific proficient networks.

The main aim of the 2nd European Congress on Hematology and Blood Disorders is to encourage eminent research and practical impression in an atmosphere of true global collaboration among researchers by bringing together yet again the world-class scientists, Worldwide Societies, and Industrial heads to talk over the up-to-date developments and innovations in the fields of hematology, blood disorders, and infectious diseases with colleagues from various countries.

Advantages of Conference:

  • Opportunity to connect with the hosts and fellow attendees
  • Wider reach to across the world
  • Reach the target the group directly and exchange the views of each other

Who can take part?

  • Scientists
  • Doctors
  • Researchers
  • Professors
  • Students
  • Engineers and Ph.D. scholars
  • Directors of companies
  • Criteria to be considered for Scoring

The abstract will be reviewed according to the following criteria:

  • Originality of concept/approach and level of innovativeness
  • Significance/impact/relevance to conference theme
  • Quality of research design/theoretical argument
  • Conclusions and interpretations of results
  • Presentation style: Coherence and clarity of structure

Abstract Peer-review Process/Guidelines:

The Reviewing Committee of Conference ensures high-quality peer review process for all abstracts submitted to ensure adherence to the conference scope and abstracts which have passed this initial screening are then assigned to the session chair / review committee for evaluation.

The decision of abstract acceptance will be decided by a panel of experts emphasizing whether the findings and / or conclusions are novel and make useful contributions to the field.

The committee operates a single / double-blind peer review process for all the abstracts submitted, where both the reviewer and the author remain anonymous.

Once the reviews have been received, the review committee decides to accept or reject a manuscript, or to request revisions from the author in response to the reviewers’ comments. If the decision tends to be minor revision or major revision, authors will be given 14 days to resubmit the revised abstract.


Organizing Committee

Jean Mercier Ythier

University of Paris Panthéon-Assas


Natarajan (raj) Muthusamy DVM.,Ph.D.

The Ohio State University


Jean-Antoine Ribeil

Necker University Hospital


Prof.Dr.Seyed Saeid Zamanieh Shahri, MD

California Northstate University


Renowned Speakers

Bene Ekine-Afolabi

ZEAB Therapeutic LTD

United kingdom

Ani Bilanishvili

Ivane Javakhishvili Tbilisi State University


Michal Stros

Institute of Biophysics AS CR

Czech republic

Suellen Cristina Roussenq

Universidade do Estado de Santa Catarina


Media Partners/Collaboration